The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $103.30

Today's change-0.73 -0.70%
Updated April 21 4:02 PM EDT. Delayed by at least 15 minutes.
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $103.30

Today's change-0.73 -0.70%
Updated April 21 4:02 PM EDT. Delayed by at least 15 minutes.

Reversal following new 52-week high

Quest Diagnostics Inc closed lower Friday, dropping (U.S.)$0.73 or 0.70% to (U.S.)$103.30 after setting a new 52-week high. Over the last five days, shares have gained 6.22% and are currently 1.85% off of the 52-week high. Shares have outperformed the S&P 500 by 25.44% during the last year.

Key company metrics

  • Open(U.S.) $104.20
  • Previous close(U.S.) $104.03
  • High(U.S.) $105.25
  • Low(U.S.) $103.18
  • Bid / Ask-- / --
  • YTD % change+12.40%
  • Volume2,212,010
  • Average volume (10-day)1,008,423
  • Average volume (1-month)876,227
  • Average volume (3-month)880,361
  • 52-week range(U.S.) $73.21 to (U.S.) $105.25
  • Beta0.66
  • Trailing P/E20.67×
  • P/E 1 year forward18.71×
  • Forward PEG2.38×
  • Indicated annual dividend(U.S.) $1.80
  • Dividend yield1.74%
  • Trailing EPS(U.S.) $5.00
Updated April 21 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.07%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue1,8991,8611,8851,906
Total other revenue--------
Total revenue1,8991,8611,8851,906
Gross profit734760729753
Total cost of revenue1,1651,1011,1561,153
Total operating expense1,6201,5851,5631,484
Selling / general / administrative437363407429
Research & development--------
Depreciation / amortization17181817
Interest expense (income), net operating--------
Unusual expense (income)--963-115
Other operating expenses, total17-210
Operating income279276322422
Interest income (expense), net non-operating---36-37-35
Gain (loss) on sale of assets--------
Other--------
Income before tax253251300392
Income after tax175167205209
Income tax, total788495183
Net income164155192195
Total adjustments to net income--0-2-1
Net income before extra. items164155192195
Minority interest-11-12-13-14
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items164155190194
Inc. avail. to common incl. extra. items164155190194
Diluted net income164155192194
Dilution adjustment----2--
Diluted weighted average shares141139142142
Diluted EPS excluding extraordinary itemsvalue per share1.161.121.351.37
Dividends per sharevalue per share0.450.400.400.40
Diluted normalized EPSvalue per share1.161.571.370.93